Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - NUTRANOMICS, INC. | ex-99_1.htm |
1 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) |
October 3, 2013 |
|||
NUTRANOMICS INC. |
||||
(Exact name of registrant as specified in its charter) |
||||
Nevada |
000-53551 |
98 0603540 |
||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
||
11487 South 700 East, Salt Lake City, UT 84020 |
-- |
|||
(Address of principal executive offices) |
(Zip Code) |
|||
Registrant’s telephone number, including area code |
801-576-8350 |
|||
21 Luke Street, Vatuwaga, Suva, Fiji |
||||
(Former name or former address, if changed since last report.) |
||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 |
FD Disclosure |
On October 3, 2013 Nutranomics, Inc., disseminated a press release regarding the development of a new enhanced brain function product line and finalization of purchase order. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits
99.1 |
Press Release disseminated on October 3, 2013 |